Finance

Lists
AYTU:NASDAQ
Aytu Biopharma Inc
2,02 USD
-0,25%
(-0,0050) 1D
12-окт., 12:43:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AYTU...
Open
1,99 USD
High
2,04 USD
Low
1,98 USD
Mkt. cap
21,90 млн
Avg. vol.
41,13 миң
Volume
15,94 миң
52-wk high
3,06 USD
52-wk low
1,80 USD
EPS
-1,16 USD
Beta
0,17
Shares outstanding
10,87 млн
No. of employees
76
Open
1,99 USD
High
2,04 USD
Low
1,98 USD
Mkt. cap
21,90 млн
Avg. vol.
41,13 миң
Volume
15,94 миң
52-wk high
3,06 USD
52-wk low
1,80 USD
EPS
-1,16 USD
Beta
0,17
Shares outstanding
10,87 млн
No. of employees
76
News stories
From web sources and news partners
About Aytu Biopharma Inc
CEO-
Employees76
Founded2002
HeadquartersДенвер, Колорадо, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websiteaytubio.com
Analyst ratings
Based on 3 analysts giving stock ratings to AYTU in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AYTU in the last 3 months.
Highest
Current 2,02 USD
15,00 USD (+642,57%)
Average
9,67 USD (+378,71%)
Lowest
7,00 USD (+246,53%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
15,00 USD
+642,6%
09/29/2026
Naz Rahman
Maxim Group
Buy
Reiterated
7,00 USD
+246,5%
09/24/2026
Thomas Flaten
Lake Street
Buy
Maintained
7,00 USD
+246,5%
09/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
13,89 млн
15,16 млн
12,41 млн
16,11 млн
Cost of goods sold
4,70 млн
5,54 млн
4,81 млн
5,70 млн
Cost of revenue
4,70 млн
5,54 млн
4,81 млн
5,70 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,25 млн
11,07 млн
10,90 млн
10,42 млн
Operating expense
10,69 млн
11,59 млн
11,66 млн
11,19 млн
Total operating expenses
15,39 млн
17,14 млн
16,48 млн
16,88 млн
Operating income
-1,50 млн
-1,97 млн
-4,06 млн
-777,00 миң
Other non operating income
3,98 млн
-8,05 млн
-1,11 млн
1,16 млн
EBT including unusual items
1,96 млн
-10,58 млн
-5,61 млн
-4,00 миң
EBT excluding unusual items
1,96 млн
-10,58 млн
-5,61 млн
-4,00 миң
Income tax expense
-
-
10,00 миң
11,00 миң
Effective tax rate
-
-
-0,18%
-275,00%
Other operating expenses
-
-
-
-
Net income
1,96 млн
-10,58 млн
-5,62 млн
-15,00 миң
Net profit margin
14,15%
-69,79%
-45,27%
-0,09%
Earnings per share
-0,09
-0,23
-0,41
-0,06
Interest and investment income
-
-
-
-
Interest expense
-516,00 миң
-560,00 миң
-436,00 миң
-383,00 миң
Net interest expenses
-516,00 миң
-560,00 миң
-436,00 миң
-383,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-701,00 миң
-1,08 млн
-2,94 млн
344,00 миң
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору